Publications by authors named "Ken Hong Lim"

Claim this Profile
D
Daratumumab-Based Combinational Therapy as Second-Line Treatment of Relapsed-Refractory Multiple Myeloma: A Single-Center Experience.
Oscar C Y Yang, Yi-Hao Chiang, Caleb Gonshen Chen, Yu-Cheng Chang, Ming-Chih Chang, Ken-Hong Lim

Cancer Rep (Hoboken)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.
Ruben Mesa, Harinder Gill, Lei Zhang, Jie Jin, Keita Kirito, Ken-Hong Lim

Lancet Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic manifestations and targeted management of cardiac complications in cardiac-involved DLBCL: a retrospective case series.
Jen-Yu Chuang, Kuan-Ting Chen, Johnson Lin, Ken-Hong Lim, Meng-Ta Sung

Cardiooncology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag-Induced Cerebral Venous Thrombosis: A Case Report and Literature Review.
I-Wei Lin, Ken-Hong Lim, Yen-Chang Huang, Meng-Ta Sung

Case Rep Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy Cell Leukaemia with an Uncommon Pulmonary Presentation: A Case Report and Review of the Literature.
Jen-Yu Chuang, Meng-Ta Sung, Kuan-Chih Kuo, Jie-Yang Jhuang, Ken-Hong Lim

Eur J Case Rep Intern Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations.
Yu-Cheng Chang, Hui-Jen Tsai, To-Yu Huang, Nai-Wen Su, Ying-Wen Su, Ken-Hong Lim

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implication of serum HLA-G in angiogenesis of multiple myeloma.
Chi Wang, Nai-Wen Su, Kate Hsu, Chen-Wei Kao, Ming-Chih Chang, Ken-Hong Lim

Mol Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of fentanyl buccal soluble film in cancer patients with inadequate breakthrough pain control.
Yi-Hao Chiang, Ching-Ting Lien, Wen-Hao Su, Tsung-Yu Yen, Yu-Jen Chen, Ken-Hong Lim

BMC Palliat Care· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering clonal architecture and evolutionary dynamics of secondary acute myeloid leukemia and donor-derived myelodysplastic syndrome using single-cell multi-omics analysis.
Meng-Ta Sung, Lo-Ho Chen, Ya-Wen Chiang, Jie-Yang Jhuang, Yu-Chen Chang, Ken-Hong Lim

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating Potential Cardiovascular Toxicity of Two Anti-Leukemia Drugs of Asciminib and Ponatinib in Zebrafish Embryos.
Huan-Chau Lin, Ferry Saputra, Gilbert Audira, Yu-Heng Lai, Marri Jmelou M Roldan, Ken-Hong Lim

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated naïve γδ T cells accelerate deep molecular response to BCR-ABL inhibitors in patients with chronic myeloid leukemia.
Yu-Cheng Chang, Yi-Hao Chiang, Kate Hsu, Chih-Kuang Chuang, Chen-Wei Kao, Ken-Hong Lim

Blood Cancer J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms.
Ken-Hong Lim, Shinobu Matsuura, Bing Xu

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine exhausts CD8 T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression.
Chun-Chia Cheng, Hsin-Chi Lin, Ya-Wen Chiang, Jungshan Chang, Zong-Lin Sie, Ken-Hong Lim

Cancer Immunol Immunother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution and heterogeneity in advanced systemic mastocytosis revealed by single-cell DNA sequencing.
Ken-Hong Lim, Jo-Ning Wu, To-Yu Huang, Jie-Yang Jhuang, Yu-Cheng Chang

Blood Adv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duplicated and DNA Methyltransferase Genes Play Essential and Non-Overlapped Functions on Modulating Behavioral Control in Zebrafish.
Yu-Heng Lai, Gilbert Audira, Sung-Tzu Liang, Petrus Siregar, Michael Edbert Suryanto, Ken-Hong Lim

Genes (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAFF-driven NLRP3 inflammasome activation in B cells.
Ken-Hong Lim, Lih-Chyang Chen, Kate Hsu, Chia-Ching Chang, Chia-Yu Chang

Cell Death Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia.
Ming-Chin Chang, Hung-I Cheng, Kate Hsu, Yen-Ning Hsu, Chen-Wei Kao, Ken-Hong Lim

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers.
Yi-Fang Chang, Ken-Hong Lim, Ya-Wen Chiang, Zong-Lin Sie, Jungshan Chang

BMC Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers.
Chun-Chia Cheng, Hsin-Chi Lin, Kaun-Jer Tsai, Ya-Wen Chiang, Ken-Hong Lim

Mol Carcinog· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
Chun-Chia Cheng, Po-Nien Liao, Ai-Sheng Ho, Ken-Hong Lim, Jungshan Chang

J Biomed Sci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer.
Chun-Chia Cheng, Kuei-Fang Chou, Cheng-Wen Wu, Nai-Wen Su, Cheng-Liang Peng, Ken-Hong Lim

Lung Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
Chun-Chia Cheng, Jungshan Chang, Stanley Ching-Cheng Huang, Huan-Chau Lin, Ai-Sheng Ho, Ken-Hong Lim

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline variations at , , and and the risk of myeloproliferative neoplasms in Taiwanese population.
Yi-Hao Chiang, Yu-Cheng Chang, Huan-Chau Lin, Ling Huang, Chun-Chia Cheng, Ken-Hong Lim

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms.
Yu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, Caleb Gon-Shen Chen, Ling Huang, Ken-Hong Lim

Med Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia.
Ken-Hong Lim, Caleb Gon-Shen Chen, Yu-Cheng Chang, Yi-Hao Chiang, Chen-Wei Kao

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis